<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.1: Resistance Training for Sarcopenia Prevention</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Movement */
        .module-header {
            background: linear-gradient(135deg, #0f766e 0%, #14b8a6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f766e;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0f766e;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #14b8a6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #14b8a6;
        }

        .term-item .term {
            font-weight: 700;
            color: #0f766e;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f766e;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f0fdfa 0%, #f0fdfa 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #99f6e4;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #0f766e;
            font-weight: 600;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0f766e 0%, #14b8a6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #14b8a6, #0f766e);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0f766e 0%, #14b8a6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #0f766e;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .question-number {
            position: absolute;
            top: -12px;
            left: 20px;
            background: #0f766e;
            color: white;
            width: 28px;
            height: 28px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 600;
            font-size: 13px;
        }

        .reveal-btn {
            background: #0f766e;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #065f46;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f0fdf4;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #ffffff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }

        .lesson-footer .brand {
            color: #0f766e;
            font-weight: 600;
            margin: 0;
            font-size: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Movement and Strength Training</p>
            <h1 class="lesson-title">Lesson 8.1: Resistance Training for Sarcopenia Prevention</h1>
            <div class="lesson-meta">
                <span class="meta-item">30 min read</span>
                <span class="meta-item">Lesson 1 of 5</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Sarcopenia Crisis</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Estrogen & Muscle Synthesis</a></li>
                <li><a href="#section3"><span class="section-num">3</span>VITAL Method Integration</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Hypertrophy vs. Strength</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Protocol: Loading & RPE</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Anabolic Resistance Factors</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define sarcopenia and identify its accelerated progression during the menopausal transition.</li>
                <li>Explain the physiological mechanism by which estrogen decline impairs satellite cell function.</li>
                <li>Analyze the synergy between the "V" (Vascular) and "I" (Insulin) pillars of the VITAL Methodâ„¢ in skeletal muscle health.</li>
                <li>Design a resistance training protocol utilizing progressive overload and appropriate RPE (Rate of Perceived Exertion).</li>
                <li>Evaluate the role of protein timing in overcoming age-related anabolic resistance.</li>
            </ul>
        </div>

        <!-- Welcome Box -->
        <div class="welcome-box">
            <h3>The Silent Thief of Longevity</h3>
            <p>While hot flashes and mood swings often dominate the conversation around menopause, a more insidious change is occurring beneath the surface: the rapid loss of skeletal muscle mass. This condition, known as <span class="highlight">sarcopenia</span>, is not just about aesthetics or "toning." It is a fundamental shift in metabolic health, bone density, and functional independence. As a Menopause Support Coach, your ability to guide clients through effective resistance training is perhaps the single most impactful intervention for their long-term vitality.</p>
        </div>

        <!-- Key Terms -->
        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Sarcopenia</p>
                    <p class="definition">The age-related progressive loss of skeletal muscle mass and strength, which accelerates significantly during the perimenopausal transition.</p>
                </div>
                <div class="term-item">
                    <p class="term">Satellite Cells</p>
                    <p class="definition">Precursor cells to skeletal muscle that are responsible for muscle repair and growth; their activity is highly dependent on estrogen levels.</p>
                </div>
                <div class="term-item">
                    <p class="term">Anabolic Resistance</p>
                    <p class="definition">A blunted muscle protein synthesis response to protein ingestion and resistance exercise, common in post-menopausal women.</p>
                </div>
                <div class="term-item">
                    <p class="term">Myokines</p>
                    <p class="definition">Cytokines produced and released by muscle cells during contraction that exert anti-inflammatory effects on the entire body.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The Sarcopenia Crisis in Menopause</h2>

        <p>Skeletal muscle is our largest metabolic organ. Beyond movement, it serves as the primary site for glucose disposal and a reservoir for amino acids. However, women face a unique challenge: the "estrogen cliff." While men experience a gradual decline in testosterone, women experience a precipitous drop in estrogen that directly impacts muscle quality.</p>

        <p>A 2022 longitudinal study (n=1,248) observed that women lose approximately <span class="highlight">0.6% to 1% of their lean mass per year</span> during the menopausal transition, but the loss of <strong>strength</strong> occurs at 2-3 times that rate. This "strength-mass dissociation" suggests that muscle qualityâ€”the ability of the muscle to generate forceâ€”declines even faster than the size of the muscle itself.</p>

        <!-- Statistics Box -->
        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">10-15%</div>
                    <div class="stat-label">Mass Loss in Transition</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3.0x</div>
                    <div class="stat-label">Strength Loss vs Mass</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Higher Fall Risk</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2x</div>
                    <div class="stat-label">Insulin Resistance Risk</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Estrogen's Role in Muscle Maintenance</h2>

        <p>For years, muscle loss was attributed solely to aging or inactivity. We now know that <span class="highlight">estrogen receptors (ERÎ±)</span> are present directly on female skeletal muscle fibers. Estrogen acts as an anabolic regulator by:</p>
        
        <ul class="content-list">
            <li><strong>Satellite Cell Activation:</strong> Estrogen is required to "wake up" satellite cells to repair micro-tears caused by exercise. Without it, muscle recovery is significantly delayed.</li>
            <li><strong>Mitochondrial Efficiency:</strong> Estrogen protects the mitochondria within muscle cells, maintaining the "energy factories" needed for high-intensity movement.</li>
            <li><strong>Myosin Function:</strong> It improves the "cross-bridge" formation between muscle proteins, directly affecting the force of contraction.</li>
        </ul>

        <div class="alert-box info">
            <p class="alert-label">Practitioner Note</p>
            <p>When estrogen levels drop, the body shifts from being "pro-muscle building" to "muscle-wasting." This means your clients cannot simply "walk for fitness" anymore. They must provide a stimulus loud enough to override this hormonal shift: <strong>Heavy Resistance Training.</strong></p>
        </div>

        <h2 id="section3">The VITAL Methodâ„¢ Integration</h2>

        <p>In our <strong>VITAL Methodâ„¢</strong>, sarcopenia prevention sits at the intersection of two critical pillars:</p>

        <div class="principle-card">
            <div class="principle-title">V - Vascular & Bone Integrity</div>
            <p class="principle-text">Muscle and bone are a functional unit. You cannot strengthen bone without placing tension on it via muscle contraction (the Mechanostat Theory). Furthermore, muscle acts as a "peripheral pump," improving vascular health and reducing arterial stiffness.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">I - Insulin & Metabolic Optimization</div>
            <p class="principle-text">Skeletal muscle is the primary "sink" for dietary glucose. As muscle mass decreases, the risk of insulin resistance skyrockets. By building muscle, we increase the client's metabolic flexibility and prevent the "menopause middle."</p>
        </div>

        <h2 id="section4">Hypertrophy vs. Strength: What Does She Need?</h2>

        <p>Many women are coached to use "light weights and high reps" to avoid bulk. For the menopausal client, this is biologically counterproductive. To combat sarcopenia, we must target <strong>Type II (fast-twitch) muscle fibers</strong>, which are the first to atrophy during menopause.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Training Goal</th>
                        <th>Rep Range</th>
                        <th>Intensity (% 1RM)</th>
                        <th>Primary Benefit for Menopause</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Strength</strong></td>
                        <td>1 - 5</td>
                        <td>85% - 100%</td>
                        <td>Neurological drive, bone density, Type II fiber recruitment.</td>
                    </tr>
                    <tr>
                        <td><strong>Hypertrophy</strong></td>
                        <td>6 - 12</td>
                        <td>65% - 85%</td>
                        <td>Increasing muscle cross-sectional area (size) and metabolic rate.</td>
                    </tr>
                    <tr>
                        <td><strong>Endurance</strong></td>
                        <td>15 - 20+</td>
                        <td>&lt; 60%</td>
                        <td>Minimal impact on sarcopenia; primarily cardiovascular.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section5">The Protocol: Loading & RPE</h2>

        <p>To override anabolic resistance, the stimulus must be significant. We utilize the <span class="highlight">RPE Scale (Rate of Perceived Exertion)</span> to ensure the client is working at an intensity that triggers adaptation.</p>

        <p>For a Menopause Support Coach, a "safe" but effective protocol includes:</p>
        <ul class="content-list">
            <li><strong>Frequency:</strong> 2â€“3 full-body sessions per week.</li>
            <li><strong>Intensity:</strong> RPE 8-9 (meaning the client could only do 1-2 more reps with good form).</li>
            <li><strong>Selection:</strong> Compound movements (Squats, Hinges, Pushes, Pulls) to maximize hormonal response.</li>
            <li><strong>Progressive Overload:</strong> Increasing weight, reps, or decreasing rest periods every 2 weeks.</li>
        </ul>

        <!-- Case Study -->
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Overcoming Sarcopenic Obesity</p>
                    <p class="subtitle">Applying the VITAL Methodâ„¢ to Elena</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, Age 54</h4>
                        <p>Post-menopausal | Symptoms: Fatigue, "Skinny Fat" appearance, Loss of grip strength.</p>
                    </div>
                </div>
                <p><strong>Initial Assessment:</strong> Elena was walking 10,000 steps a day but noticed her clothes were getting tighter and she felt "weak." DEXA scan showed low muscle mass (sarcopenia) despite a "normal" BMI.</p>
                <p><strong>Intervention:</strong> 
                    <ul>
                        <li>Replaced 3 days of walking with 2 days of heavy resistance training (Sets of 8, RPE 8).</li>
                        <li>Increased protein intake to 1.6g/kg of body weight, focused on the "anabolic window" post-workout.</li>
                        <li>Implemented the <strong>I (Insulin)</strong> pillar by timing carbohydrate intake around training.</li>
                    </ul>
                </p>
                <p><strong>Outcome:</strong> After 16 weeks, Elena increased her lean mass by 2.4 lbs and decreased her visceral fat by 1.8 lbs. Her grip strength increased by 15%, and her daytime fatigue vanished.</p>
            </div>
        </div>

        <h2 id="section6">Anabolic Resistance Factors</h2>

        <p>It isn't just about the lifting; it's about the body's ability to respond to the lift. Menopausal women experience <span class="highlight">anabolic resistance</span>, where the same amount of protein or exercise that used to build muscle no longer works. To solve this:</p>

        <div class="principle-card">
            <div class="principle-title">1. Leucine Threshold</div>
            <p class="principle-text">Ensure each meal contains 3-4g of Leucine (found in ~30-40g of high-quality protein) to "flip the switch" for muscle protein synthesis.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">2. Recovery Hygiene</div>
            <p class="principle-text">Because estrogen is low, inflammation stays higher for longer. Clients may need 48-72 hours between intense sessions to fully recover.</p>
        </div>

        <!-- Check Your Understanding -->
        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of sarcopenia and resistance training.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is the loss of estrogen specifically detrimental to muscle repair in women?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Estrogen receptors (ERÎ±) are located on muscle fibers. Estrogen is required for the activation and proliferation of satellite cells, which are the precursor cells responsible for repairing and building new muscle tissue. Without estrogen, the "repair signal" is significantly weakened.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">According to the VITAL Methodâ„¢, how does building muscle support the "V" (Vascular) pillar?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Muscle acts as a peripheral pump for the vascular system, improving blood flow and reducing arterial stiffness. Additionally, through the Mechanostat Theory, muscle contraction creates the necessary tension on bones to maintain and increase bone mineral density, protecting against osteoporosis.</div>
            </div>
        </div>

        <!-- Key Takeaways -->
        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Sarcopenia is a primary driver of metabolic and functional decline in menopause.</li>
                <li>Strength (force production) declines significantly faster than muscle mass during the transition.</li>
                <li>Resistance training must be high-intensity (RPE 8+) to overcome hormonal anabolic resistance.</li>
                <li>Type II muscle fibers are the first to be lost and must be targeted with compound, heavy movements.</li>
                <li>Muscle is a "metabolic sink" that is essential for maintaining insulin sensitivity (The "I" in VITAL).</li>
            </ul>
        </div>

        <!-- References -->
        <div class="references-box">
            <h4>References & Further Reading</h4>
            <p>1. Collins, B.C., et al. (2019). "Estrogen Regulates the Satellite Cell Compartment in Females." <i>Cell Reports.</i></p>
            <p>2. Greising, S.M., et al. (2022). "Estradiol and mTORC1 Signaling in Skeletal Muscle of Women." <i>Journal of Cachexia, Sarcopenia and Muscle.</i></p>
            <p>3. Maltais, M.L., et al. (2019). "Changes in Muscle Mass and Strength After Menopause." <i>Menopause: The Journal of The North American Menopause Society.</i></p>
            <p>4. Nuckols, G. (2020). "The Impact of Sex Hormones on Muscle Adaptations." <i>Sports Medicine.</i></p>
            <p>5. SipilÃ¤, S., et al. (2020). "Muscle and Bone Mass in Middle-Aged Women: A 10-Year Follow-up." <i>Journal of Bone and Mineral Research.</i></p>
            <p>6. Pasiakos, S.M., et al. (2021). "The Effects of Protein Ingestion on Muscle Protein Synthesis in Aging Women." <i>The Journal of Nutrition.</i></p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Certified Menopause Support Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Confidential & Proprietary.</p>
        </footer>
    </div>
</body>

</html>